COLONAID Drug Patent Profile
✉ Email this page to a colleague
When do Colonaid patents expire, and when can generic versions of Colonaid launch?
Colonaid is a drug marketed by Medpointe Pharm Hlc and is included in two NDAs.
The generic ingredient in COLONAID is atropine sulfate; diphenoxylate hydrochloride. There is one drug master file entry for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for COLONAID?
- What are the global sales for COLONAID?
- What is Average Wholesale Price for COLONAID?
Summary for COLONAID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| DailyMed Link: | COLONAID at DailyMed |
US Patents and Regulatory Information for COLONAID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medpointe Pharm Hlc | COLONAID | atropine sulfate; diphenoxylate hydrochloride | SOLUTION;ORAL | 085735-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Medpointe Pharm Hlc | COLONAID | atropine sulfate; diphenoxylate hydrochloride | TABLET;ORAL | 085737-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
